Myasthenia Gravis Foundation of America Inc (EIN 135672224) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1952

Legal Domicile

Principal Officer

Justin Stachtiaris

Phone

9493073330

Tax Period

2025-01-01 to 2025-12-31

Myasthenia Gravis Foundation of America Inc, founded in 1952, is a community nonprofit in the Medical Research sector that reported $7.6M in total revenue in fiscal year 2025. Revenue surged 33% from the prior year, signaling strong growth momentum. Expenses of $7.1M left a modest 6% surplus.

Mission

Committed to finding a cure for myasthenia gravis and closely related disorders, improving treatment options, and providing information and support to people with myasthenia gravis through research, education, community programs and advocacy.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $6,346,619

Program Service Revenue $585,239

Investment Income $502,584

Other Revenue $125,370

TOTAL REVENUE $7,559,812

Expense Breakdown

Grants Paid $849,999

Salaries & Benefits $2,197,998

Fundraising Expenses $596,247

Program Expenses $5,506,368

Other Expenses $4,029,788

TOTAL EXPENSES $7,077,785

Year-over-Year Comparison

	2025	2024	Change
Revenue	$7,559,812	$5,670,792	+0.3%
Expenses	$7,077,785	$5,078,413	+0.4%
Net Income	$482,027	$592,379	-0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

500

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$540,872

Total Directors

Key Employees

$178,314

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Robert Thomas	Chair	8.00	Officer Director	$0	$0	$0
Adrejia Boutte	Secretary	8.00	Officer Director	$0	$0	$0
Ani Maitra	Director	4.00	Director	$0	$0	$0
Justin Stachtiaris	Treasurer and Vice Chair	8.00	Officer Director	$0	$0	$0
Callum Schjerning	Director	4.00	Director	$0	$0	$0
Clyde Hosein	Director	4.00	Director	$0	$0	$0
Erin Harrigan	Director (beg 10/25)	4.00	Director	$0	$0	$0
Kelly Gwathmey MD	Director	4.00	Director	$0	$0	$0
Kevin O'Connor MD	Director	4.00	Director	$0	$0	$0
Kyle Sell	Director	4.00	Director	$0	$0	$0
Paul Strumph MD	Director	4.00	Director	$0	$0	$0
Richard J Nowak MD	Director	4.00	Director	$0	$0	$0
Todd Fowler	Director (beg 12/25)	4.00	Director	$0	$0	$0
Wes Caudle	Director (beg 12/25)	4.00	Director	$0	$0	$0
Mark Willig	Director (beg 12/25)	4.00	Director	$0	$0	$0
Esther Land	Director (non-voting)	0.25	Director	$0	$0	$0
Marcia Lorimer	Director (non-voting)	0.25	Director	$0	$0	$0
Mark Kalish	Director (non-voting)	0.25	Director	$0	$0	$0
Sam Schuloff	Director (non-voting)	0.25	Director	$0	$0	$0
Susan Klinger	Director (non-voting)	0.25	Director	$0	$0	$0
Brian Gladden	Director (non-voting)	0.25	Director	$0	$0	$0
Samantha Masterson	Chief Executive Officer	40.00	Officer	$330,105	$6,798	$336,903
Craig Stenger	Chief Operating Officer	40.00	Officer	$193,297	$10,672	$203,969
Michael Antonellis	Vice President, Global Marketing and Communication	40.00	Key Emp	$172,849	$5,465	$178,314
Danielle Kerkovich	Vice President, Global Research	40.00	Highest	$128,742	$50	$128,792
Daryl Lee	National Director, Finance	40.00	Highest	$123,544	$15,154	$138,698
Genevieve Mvalo	National Director, Programs	40.00	Highest	$105,037	$10,070	$115,107
Katharine Stober	National Director, Academi	40.00	Highest	$100,825	$3,425	$104,250

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$7,559,812	$7,077,785	$15,271,954	$482,027
2024	$5,670,792	$5,078,413	$13,552,735	$592,379
2023	$3,555,325	$3,580,103	$12,011,651	$-24,778
2022	$4,388,529	$3,790,735	$11,363,951	$597,794
2021	$3,840,681	$3,008,153	$12,076,757	$832,528
2020	$3,577,214	$2,477,510	$10,606,667	$1,099,704
2019	$2,579,572	$2,266,013	$9,512,374	$313,559
2018	$2,585,457	$1,955,857	$8,146,592	$629,600

Myasthenia Gravis Foundation of America Inc